Cutaneous T-Cell Lymphoma in Adults

We diagnose cutaneous T-cell lymphoma, cancer of the white blood cells found in the skin, and provide personalized treatments based on the latest scientific research. Our oncologists, hematologists, and dermatologists work together to provide you with ongoing care and monitoring. Integrative medicine specialists, psycho-oncologists, and social workers are also available to provide the support you need while managing this condition.

Clinical Trials and Research Studies

Phase 2

Open-label Multicenter Phase 2 Study Evaluating the Efficacy & Safety of Daratumumab in Pediatric & Young Adult Subjects =1 & =30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Learn More

Phase 3

EA9161: A Randomized Phase III Study of the addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Learn More

Phase 3

A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Na ve Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel Genomic Biomarker DGM1

Learn More

Phase 1/2

A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

Learn More